TissueMicroscopyBench
Agents examine tissue images and answer questions about cells, staining, and changes over time.
LatchBio lists the evaluation in its V1 inventory.
- Made by
- LatchBio
- Kind
- Research science
- Level
- Expert
- Scored
- Checked automatically
- Answers
- Agent task
- Measures
- Capability
- Subject
- Biological sciences, Basic medicine
- Language
- English
- Interaction
- Agentic
- Environment
- Terminal
- Items from
- Real work and use
- Refresh
- One fixed set
- Run by
- A host
- In views
- Agents, Vision, Biology and medicine
- Strongest model tested
- Claude Fable 5.2 #2 on the capability index
- Last model added
- November 2026
- Scores refreshed
- November 20th, 2026
Claude Fable 5.2 leads with 34%
Best score per model from the benchmark's own leaderboard, read on November 20th, 2026. Where a model ran with several settings or harnesses, we keep its best.
- 34.0 Claude Fable 5.2
- 29.3 Claude Opus 5.5
- 27.9 Claude Sonnet 5.5
- 25.9 GPT-6.1 Terra
- 24.5 Claude Fable 5.1
- 22.4 GPT-6.1 Sol
- 21.8
Gemini 4 Argon
- 19.7 GPT-6 Astra
- 15.7 Claude Opus 5
- 6.80 Grok 4.7
- 4.08 Grok 4.6
- 3.40
Gemini 3.8 Flash
- 2.72
DeepSeek V4.1 Flash
- 2.04 Claude Sonnet 5
- 2.04 GPT-5.6 Sol
- 2.04
Mistral Large 4
- 1.36 GLM-5.3
- 1.36 GPT-6 Luna
- 0.68 GPT-5.6 Luna
- 0.68 Kimi K3
- 0.0
Nemotron 3 Ultra
- 0.0
Nemotron 3.5 Lightning 30B-A3B
- 1 Claude Fable 5.2 LSVP 34%
- 2 Claude Opus 5.5 LSVP 29.3%
- 3 Claude Sonnet 5.5 LSVP 27.9%
- 4 GPT-6.1 Terra 25.9%
- 5 Claude Fable 5.1 LSVP 24.5%
- 6 GPT-6.1 Sol 22.4%
- 7
Gemini 4 Argon 21.8%
- 8 GPT-6 Astra 19.7%
- 9 Claude Opus 5 LSVP 15.7%
- 10 Grok 4.7 6.80%
- 11 Grok 4.6 4.08%
- 12
Gemini 3.8 Flash 3.40%
- 13
DeepSeek V4.1 Flash 2.72%
- 14 Claude Sonnet 5 LSVP 2.04%
- 15 GPT-5.6 Sol 2.04%
- 16
Mistral Large 4 2.04%
- 17 GLM-5.3 1.36%
- 18 GPT-6 Luna 1.36%
- 19 GPT-5.6 Luna 0.68%
- 20 Kimi K3 0.68%
- 21
Nemotron 3 Ultra 0%
- 22
Nemotron 3.5 Lightning 30B-A3B 0%
Source: Official TissueMicroscopyBench leaderboard
| # | Model | Score | Setting | Date | Source |
|---|---|---|---|---|---|
| 1 | Claude Fable 5.2 | 34% | LSVP, Pi | Nov 2026 | Official leaderboard |
| 2 | Claude Opus 5.5 | 29.3% | LSVP, Pi | Sep 2026 | Official leaderboard |
| 3 | Claude Sonnet 5.5 | 27.9% | LSVP, Pi | Sep 2026 | Official leaderboard |
| 4 | GPT-6.1 Terra | 25.9% | Pi | Oct 2026 | Official leaderboard |
| 5 | Claude Fable 5.1 | 24.5% | LSVP, Pi | Sep 2026 | Official leaderboard |
| 6 | GPT-6.1 Sol | 22.4% | Pi | Sep 2026 | Official leaderboard |
| 7 | | 21.8% | Pi | Sep 2026 | Official leaderboard |
| 8 | GPT-6 Astra | 19.7% | Pi | Sep 2026 | Official leaderboard |
| 9 | Claude Opus 5 | 15.7% | LSVP, Claude Code | Jul 2026 | Official leaderboard |
| 10 | Grok 4.7 | 6.80% | Pi | Sep 2026 | Official leaderboard |
| 11 | Grok 4.6 | 4.08% | Grok Build | Aug 2026 | Official leaderboard |
| 12 | | 3.40% | Pi | Sep 2026 | Official leaderboard |
| 13 | | 2.72% | Pi | Sep 2026 | Official leaderboard |
| 14 | Claude Sonnet 5 | 2.04% | LSVP, Claude Code | Jun 2026 | Official leaderboard |
| 15 | GPT-5.6 Sol | 2.04% | Pi | Jul 2026 | Official leaderboard |
| 16 | | 2.04% | Pi | Oct 2026 | Official leaderboard |
| 17 | GLM-5.3 | 1.36% | Pi | Aug 2026 | Official leaderboard |
| 18 | GPT-6 Luna | 1.36% | Pi | Sep 2026 | Official leaderboard |
| 19 | GPT-5.6 Luna | 0.68% | Pi | Jul 2026 | Official leaderboard |
| 20 | Kimi K3 | 0.68% | Pi | Jul 2026 | Official leaderboard |
| 21 | | 0% | Pi | Jun 2026 | Official leaderboard |
| 22 | | 0% | Pi | Aug 2026 | Official leaderboard |
6 models have held number one on the official leaderboard since 2023
Lab claims count from the day the card came out, independent runs from the model’s release.
Source: Official TissueMicroscopyBench leaderboard
Scores over time
All the scores we have, one dot each, so a model tested at several settings appears more than once.
Source: Official TissueMicroscopyBench leaderboard
No lab model card reports it yet
We read the headline results of 540 launch posts from 57 labs, and none of them list this benchmark.
More in Science and reasoning
- GPQA Diamond In use 198 graduate-level 'Google-proof' multiple-choice questions in biology, chemistry and physics.
Gemini 4 Carbon 97%
- Terminal-Bench-Science In use 70 scientific research-workflow tasks across five science areas, run in Harbor containers. Hidden tests give the resolution rate. GPT-6 Astra 68.1%
- BioMysteryBench In use Bioinformatics problems on anonymized real datasets that require real analysis with tools. Rubric-graded, with human-solvable and human-difficult splits. Claude Fable 5.2 83.7%
- FrontierScience In use Models solve physics, chemistry, and biology problems in an Olympiad track graded by short answer and a Research track graded by 10-point rubrics.
Intern-S2-397B 87%
- HiPhO In use Models solve theory problems from 2024 and 2025 physics olympiad exams, some with diagrams. Official marking schemes grade answers and steps, mapped to medal levels.
Gemini 3 Pro 78.3%
- LABBench2 In use 11 biology research sub-tasks (literature, figures, tables, patents, trials and more) with tool access. Macro-averaged accuracy. GPT-5.2 60.9%
Data audit
10 of 11 checks pass, 1 warning. Look first at the Task access check. We don’t know whether the tasks are public. Every benchmark
Catalog record 1 warning 1 pass
- Warning Task access We don’t know whether the tasks are public.
- Pass Confidence Checked against a primary source.
Scores 5 pass
- Pass Independent runs Scores from the official leaderboard (22 entries).
- Pass Models scored 22 models we track.
- Pass Newest score The newest is from November 2026, for Claude Fable 5.2.
- Pass Frontier models 8 of the top 10 have a score, led by Claude Fable 5.2 (#2).
- Pass Headroom The best is 34%, under 85%, so it still separates models.
Leaderboard import 3 pass
- Pass Importer We read the board on benchmarks.bio: 30 rows for models we track at the last read.
- Pass Last read November 20th, 2026.
- Pass Read worked The last read worked.
Consistency 1 pass 1 note
- Note Lab claims No model has both a lab number and an independent run.
- Pass Known issues No published audit found problems.